KPTI
Karyopharm Therapeutics (KPTI)
$64
About Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.
Details
Daily high
$9.00
Daily low
$8.54
Price at open
$8.87
52 Week High
$10.99
52 Week Low
$3.65
Market cap
194.8M
Dividend yield
0.00%
Volume
295,536
Avg. volume
372,032
P/E ratio
-.52
Karyopharm Therapeutics News
Details
Daily high
$9.00
Daily low
$8.54
Price at open
$8.87
52 Week High
$10.99
52 Week Low
$3.65
Market cap
194.8M
Dividend yield
0.00%
Volume
295,536
Avg. volume
372,032
P/E ratio
-.52